Cubic Asset Management, LLC Gilead Sciences, Inc. Transaction History

Cubic Asset Management, LLC

$417 Million
Q1 2024

A detailed history of Cubic Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cubic Asset Management, LLC holds 20,867 shares of GILD stock, worth $1.93 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

20,867

Previous 20,502 1.78%

Holding current value

$1.93 Million

Previous $1.66 Million 7.95%

% of portfolio

0.37%

Previous 0.43%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$71.58 - $87.29 $26,126 - $31,860	365 Added 1.78%	20,867 $1.53 Million
Q4 2023 Jan 24, 2024	SELL	$73.27 - $83.09 $8,792 - $9,970	-120 Reduced 0.58%	20,502 $1.66 Million
Q3 2023 Nov 01, 2023	SELL	$73.94 - $80.67 $12,939 - $14,117	-175 Reduced 0.84%	20,622 $1.55 Million
Q1 2023 Apr 26, 2023	SELL	$77.31 - $88.08 $36,722 - $41,838	-475 Reduced 2.23%	20,797 $1.73 Million
Q4 2022 Jan 30, 2023	BUY	$62.32 - $89.47 $28,729 - $41,245	461 Added 2.22%	21,272 $1.83 Million
Q3 2022 Oct 24, 2022	BUY	$59.54 - $68.01 $1,071 - $1,224	18 Added 0.09%	20,811 $1.28 Million
Q2 2022 Jul 25, 2022	SELL	$57.72 - $65.01 $23,088 - $26,004	-400 Reduced 1.89%	20,793 $1.29 Million
Q1 2022 Apr 25, 2022	BUY	$57.92 - $72.58 $13,032 - $16,330	225 Added 1.07%	21,193 $1.26 Million
Q4 2021 Jan 24, 2022	SELL	$64.88 - $73.64 $1,297 - $1,472	-20 Reduced 0.1%	20,968 $1.52 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $551,876 - $595,413	-8,153 Reduced 27.98%	20,988 $1.47 Million
Q3 2021 Oct 25, 2021	BUY	$67.69 - $73.03 $495,693 - $534,798	7,323 Added 33.56%	29,141 $2.09 Million
Q2 2021 Jul 23, 2021	SELL	$63.47 - $69.35 $7,489 - $8,183	-118 Reduced 0.54%	21,818 $1.5 Million
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $24,300 - $27,726	-405 Reduced 1.81%	21,936 $1.42 Million
Q4 2020 Jan 28, 2021	SELL	$56.65 - $64.55 $52,797 - $60,160	-932 Reduced 4.0%	22,341 $1.3 Million
Q3 2020 Oct 27, 2020	SELL	$62.1 - $78.08 $149,847 - $188,407	-2,413 Reduced 9.39%	23,273 $1.47 Million
Q2 2020 Jul 24, 2020	SELL	$72.34 - $84.0 $10,851 - $12,600	-150 Reduced 0.58%	25,686 $1.98 Million
Q1 2020 Apr 27, 2020	BUY	$62.63 - $80.22 $68,266 - $87,439	1,090 Added 4.4%	25,836 $1.93 Million
Q4 2019 Jan 24, 2020	SELL	$61.62 - $67.78 $430,415 - $473,443	-6,985 Reduced 22.01%	24,746 $1.61 Million
Q3 2019 Oct 28, 2019	BUY	$62.51 - $69.0 $625 - $690	10 Added 0.03%	31,731 $2.01 Million
Q2 2019 Jul 29, 2019	SELL	$61.87 - $69.38 $65,953 - $73,959	-1,066 Reduced 3.25%	31,721 $2.14 Million
Q1 2019 Apr 29, 2019	SELL	$62.53 - $70.05 $87,229 - $97,719	-1,395 Reduced 4.08%	32,787 $2.13 Million
Q4 2018 Jan 28, 2019	SELL	$60.54 - $79.0 $196,452 - $256,355	-3,245 Reduced 8.67%	34,182 $2.14 Million
Q3 2018 Oct 25, 2018	BUY	$71.28 - $78.92 $460,112 - $509,428	6,455 Added 20.84%	37,427 $2.89 Million
Q2 2018 Jul 25, 2018	SELL	$64.88 - $75.68 $51,579 - $60,165	-795 Reduced 2.5%	30,972 $2.19 Million
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $37,002 - $45,110	-508 Reduced 1.57%	31,767 $2.4 Million
Q4 2017 Jan 24, 2018	BUY	$71.15 - $83.52 $145,786 - $171,132	2,049 Added 6.78%	32,275 $2.31 Million
Q3 2017 Oct 26, 2017	BUY	$72.11 - $85.47 $2.18 Million - $2.58 Million	30,226	30,226 $2.45 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubic Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubic Asset Management, LLC with notifications on news.

Account

Cubic Asset Management, LLC Gilead Sciences, Inc. Transaction History